PEN Penumbra, Inc.
Healthcare$328.20-0.15%ClosedMarket Cap: $12.91B
As of 2026-05-26
Valuation
P/E (TTM)
72.87
PEG
0.06
P/B
8.76
P/S
8.89
EV/EBITDA
60.69
DCF Value
$-99.82
FCF Yield
1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
67.4%
Operating Margin
12.9%
Net Margin
11.8%
ROE
12.3%
ROA
9.0%
ROIC
9.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $374.8M | 67.6% | $38.2M | $32.6M | $— | — |
| Q4 null | $385.4M | 68.0% | $59.2M | $47.3M | $— | — |
| FY null | $1.40B | 67.1% | $189.2M | $177.7M | $— | — |
| Q3 null | $354.7M | 67.8% | $48.8M | $45.9M | $— | — |
| Q2 null | $339.5M | 66.0% | $40.8M | $45.3M | $— | — |
| Q1 null | $324.1M | 66.6% | $40.4M | $39.2M | $— | — |
| Q4 null | $315.5M | 66.8% | $42.8M | $33.7M | $— | — |
| FY null | $1.19B | 63.2% | $9.3M | $14.0M | $— | — |
| Q3 null | $301.0M | 66.5% | $35.4M | $29.5M | $— | — |
| Q2 null | $299.4M | 54.4% | $-81.0M | $-60.2M | $— | — |
| Q1 null | $278.7M | 65.0% | $12.1M | $11.0M | $— | — |
| Q4 2023 | $284.7M | 65.7% | $35.0M | $54.2M | $1.38 | — |